Clinical trial
Vaccine Therapy in Treating Patients With Malignant Glioma
NCT00068510 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00068510 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Malignant Glioma |
| Official title | Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Biological |
| Interventions | therapeutic autologous dendritic cells |
| Enrollment | 28 |
| Start date | Jun 1, 2003 |
| Primary completion | Sep 1, 2012 |
| Completion | Sep 1, 2012 |
| First posted | Sep 11, 2003 |
| Last update posted | Aug 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: